Characterization of BNT162b2 mRNA to Evaluate Risk of Off-Target Antigen Translation.

Authors:
Patel HK; Zhang K; Utegg R; Stephens E; Salem S and 7 more

Journal:
J Pharm Sci

Publication Year: 2023

DOI:
10.1016/j.xphs.2023.01.007

PMCID:
PMC9836996

PMID:
36642376

Journal Information

Full Title: J Pharm Sci

Abbreviation: J Pharm Sci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Himakshi K. Patel, Kun Zhang, Rachael Utegg, Elaine Stephens, Shauna Salem, Heidi Welch, Jeff Ryczek, David J. Cirelli, and Thomas F. Lerch are full-time employees and may be shareholders of Pfizer Inc. Svenja Grobe, Julia Schlereth, and Andreas N. Kuhn are full-time employees and may be shareholders of BioNTech SE."

Evidence found in paper:

"Funding This study was sponsored by Pfizer Inc and BioNTech SE."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025